T1	SectionAnnotate 0 4	HPI:
T2	SectionAnnotate 2167 2188	Past Medical History:
T3	SectionAnnotate 2258 2280	Past Surgical History:
T4	SectionAnnotate 2448 2462	Family History
T5	SectionAnnotate 3083 3097	Social History
T6	SectionAnnotate 3106 3130	Social History Narrative
T7	SectionSkip 3293 3426	Current Outpatient Prescriptions:     cholecalciferol, vitamin D3, (VITAMIN D3) 2,000 unit CAP capsule, Take by mouth., Disp: , Rfl:
T8	SectionAnnotate 3431 3448	Review of Systems
T9	SectionSkip 3698 4952	Physical Examination: General appearance - alert, well appearing, and in no distress  Mental status - alert, oriented to person, place, and time  Eyes - pupils equal and reactive, 
 extraocular eye movements intact  Mouth - mucous membranes moist, pharynx normal without lesions  Neck - supple, no significant adenopathy  Lymphatics - no palpable lymphadenopathy   Chest - clear to auscultation, no wheezes, rales or rhonchi, symmetric air entry,  Heart - normal rate, regular rhythm, normal S1, S2, no murmurs, rubs, clicks or gallops  Abdomen - soft, nontender, nondistended, no masses or organomegaly  Breasts - Left breast with periareolar scar and distortion  Right breast with no masses  Back exam - full range of motion, no tenderness, palpable spasm or pain on motion  Neurological - alert, oriented, normal speech, no focal findings or movement disorder noted  Musculoskeletal - no joint tenderness, deformity or swelling  Extremities - peripheral pulses normal, no pedal edema, no clubbing or cyanosis  Skin - normal coloration and turgor, no rashes, no suspicious skin lesions noted    I personally reviewed and interpreted the following results:  No results found for this or any previous visit.     05/20/2017 MRI BREAST BX VACCUUM ASSIST LT
T10	SectionSkip 4954 5681	FINDINGS: Benefits, risks, and alternatives of the procedure were discussed with the patient and informed consent was obtained. A time out was held. The patient's left breast was prepped in the usual sterile fashion. Local anesthesia was achieved with 1% lidocaine, along with 1% lidocaine with diluted epinephrine Gadolinium based contrast (5 cc of Gadavist) was administered intravenously without difficulty and the finding in question at the posterior left 6:00 position was visualized. Using MRI guidance and grid compression, a 9 gauge vacuum assisted core biopsy device was used to obtain tissue samples. A titanium marker was placed after the biopsy. The patient tolerated procedure well with no immediate Complications.
T11	SectionSkip 5682 5886	Pathology showed proliferative fibrocystic changes without atypia.   IMPRESSIONS:  MRI-guided core biopsy of a 4 mm focus of 
 contrastenhancement in the posterior, lower (6:00) region of the left breast.
T14	SectionSkip 6853 8839	FINDINGS: The breasts demonstrate heterogeneous fibroglandular tissue. There is minimal background enhancement that is symmetric.  Right breast: There are no abnormal areas of contrast enhancement.  Left breast: Postoperative changes in the left breast with a seroma in the left breast at 12:00 extending from the nipple areolar complex to the pectoralis muscle. The seroma measures 8.6 x 4.6 cm (AP, transverse). The craniocaudal extent of the anterior portion of the seroma measures 5.1 cm in the posterior portion measures 2.9 cm. The posterior portion of the seroma measures 3.4 x 1.1 x 2.9 cm (AP, transverse, CC). There is peripheral enhancement surrounding the seroma. There is irregular peripheral enhancement along the anterolateral superior margin of the anterior portion of the seroma (postcontrast axial image 54 and 49 and sagittal image 32) and along the posterolateral aspect of the 
 anterior portion of the seroma (postcontrast axial image 42 and sagittal 39). The nodular peripheral enhancement extends to the nipple areolar complex. There is also nodular peripheral enhancement along the medial margin of the anterior portion of the seroma(postcontrast axial image 45 and sagittal image 53). The peripheral enhancement demonstrates type I kinetics. No fat plane between the peripheral enhancement of the seroma and the left pectoralis muscle. 4 x 2 x 4 mm focus of enhancement in the posterior left breast at 6:00 (postcontrast axial image 72 and sagittal image 44). Kinetics curve assessment demonstrates type I enhancement There is diffuse skin thickening, likely related to postoperative changes.  Other: Postoperative seroma in the left axilla from recent sentinel lymph node dissection measuring 6.6 x 4.0 x at least 5.5 cm (AP, transverse, CC). The full craniocaudad extent of this seroma is not imaged. There is thin peripheral enhancement surrounding the seroma, which is due to postoperative changes. There is no axillary or internal mammary lymphadenopathy.
T15	SectionAnnotate 8841 8852	IMPRESSION:
T16	SectionSkip 9546 9790	FINDINGS:  Expected intense activity is noted at the injection site at the  left breast. 3 foci of tracer uptake in the left axilla,  compatible with 
 sentinel lymph nodes.    04/21/2017 Left Breast US Guided Biopsy, Left Post-Biopsy Mammogram
T18	SectionSkip 10241 10531	FINDINGS  The breasts are heterogeneously dense, which may obscure small masses. There is an irregular mass measuring 20 millimeters with spiculated margin in the left breast at 12 o'clock.This is best seen on the tomosynthesis views. The right breast appears unremarkable.  LEFT ULTRASOUND
T19	SectionSkip 10532 11186	FINDINGS  A targeted ultrasound was performed of the left breast at 12 o'clock  located 2 centimeters from the nipple. Ultrasound is suggestive of a solid mass measuring 17 millimeters in the left breast at 12 o'clock located 2 centimeters from the nipple.This corresponds to the palpable finding of clinical concern.  IMPRESSION  Solid mass in the left breast is highly suggestive of malignancy.  Ultrasound-guided core biopsy is recommended. The referring physician was notified of these results by fax. The left axilla will be evaluated with ultrasound when the patient returns for biopsy. If there adenopathy, US guided core biopsy will be performed.
T20	SectionAnnotate 11190 11210	Assessment and Plan:
T21	TREATMENT 76 93	treatment options
T22	PROBLEM 98 131	her newly diagnosed breast cancer
T23	PROBLEM 226 239	Breast cancer
T24	PROBLEM 268 277	Stage IIb
T25	TEST 292 295	IDC
T26	PROBLEM 352 370	a left breast mass
T27	TEST 465 477	Dx mammogram
T28	PROBLEM 479 495	L irregular mass
T29	PROBLEM 507 525	spiculated margins
T30	TEST 550 552	US
T31	PROBLEM 592 602	solid mass
T32	TEST 621 649	US Guided Needle Core biopsy
T33	TEST 650 652	Gr
T34	TEST 655 658	IDC
T35	TEST 659 661	ER
T36	TEST 668 670	PR
T37	TEST 674 685	%,HER-2/neg
T38	TEST 689 692	IHC
T39	TEST 697 702	Ki-67
T40	TEST 709 713	FISH
T41	TREATMENT 738 753	Left lumpectomy
T42	TEST 795 798	IDC
T43	TEST 809 812	LVI
T44	TEST 814 821	margins
T45	PROBLEM 832 847	2/2 lymph nodes
T46	TREATMENT 877 900	extracapsular extension
T47	TEST 905 922	Postoperative MRI
T48	PROBLEM 989 1005	residual disease
T49	PROBLEM 1010 1052	a 4mm focus of enhancement in the L breast
T50	TEST 1069 1086	MRI guided biopsy
T51	TEST 1099 1119	this additional area
T52	PROBLEM 1129 1161	proliferative fibrocystic change
T53	PROBLEM 1170 1176	atypia
T54	TEST 1189 1198	BRCA test
T55	PROBLEM 1258 1262	BRCA
T56	TREATMENT 1274 1306	Surgical re-excision left breast
T57	TREATMENT 1308 1332	lumpectomy re-excision:1
T58	PROBLEM 1334 1352	Residual IDC spans
T59	PROBLEM 1361 1394	Invasive carcinoma at deep margin
T60	PROBLEM 1442 1449	tumor '
T61	PROBLEM 1529 1559	a much larger lesional  volume
T62	PROBLEM 1582 1615	the small residual tumor deposits
T63	PROBLEM 1696 1727	A much smaller residual deposit
T64	PROBLEM 1807 1828	mild left breast pain
T65	TREATMENT 1841 1863	lumpectomy re-excision
T66	PROBLEM 1916 1935	pinching" sensation
T67	TREATMENT 2085 2094	treatment
T68	PROBLEM 2210 2223	Breast cancer
T69	TEST 2313 2319	BIOPSY
T70	TREATMENT 2322 2378	EXCISION / DISSECTION AXILLARY NODE Left     MASTECTOMY
T71	TREATMENT 2379 2399	PARTIAL / LUMPECTOMY
T72	TREATMENT 2403 2427	AXILLARY LYMPHADENECTOMY
T73	PROBLEM 2499 2512	Breast cancer
T74	PROBLEM 2541 2554	Breast cancer
T75	PROBLEM 2576 2589	Breast cancer
T76	PROBLEM 2604 2617	Breast cancer
T77	PROBLEM 2667 2673	cancer
T78	PROBLEM 2679 2692	Breast cancer
T79	PROBLEM 2721 2734	Breast cancer
T80	PROBLEM 2812 2825	Breast cancer
T81	TREATMENT 2980 3016	Previous hormone replacement therapy
T82	PROBLEM 3029 3038	Allergies
T83	TREATMENT 3332 3347	cholecalciferol
T84	TREATMENT 3349 3373	vitamin D3, (VITAMIN D3)
T85	TEST 3531 3533	BP
T86	TEST 3543 3548	Pulse
T87	TEST 3554 3558	Temp
T88	TEST 3564 3565	C
T89	TEST 3585 3589	Resp
T90	TEST 3595 3597	Ht
T91	TEST 3642 3644	Wt
T92	TEST 3671 3675	SpO2
T93	TEST 3682 3685	BMI
T94	TEST 3698 3718	Physical Examination
T95	PROBLEM 3774 3782	distress
T96	TEST 3880 3905	extraocular eye movements
T97	PROBLEM 3969 3976	lesions
T98	PROBLEM 3996 4018	significant adenopathy
T99	PROBLEM 4036 4060	palpable lymphadenopathy
T100	TEST 4080 4092	auscultation
T101	PROBLEM 4097 4104	wheezes
T102	PROBLEM 4106 4111	rales
T103	PROBLEM 4115 4122	rhonchi
T104	PROBLEM 4201 4208	murmurs
T105	PROBLEM 4210 4214	rubs
T106	PROBLEM 4216 4222	clicks
T107	PROBLEM 4226 4233	gallops
T108	PROBLEM 4251 4260	nontender
T109	PROBLEM 4262 4274	nondistended
T110	PROBLEM 4279 4285	masses
T111	PROBLEM 4289 4301	organomegaly
T112	PROBLEM 4313 4324	Left breast
T113	PROBLEM 4330 4375	periareolar scar and distortion  Right breast
T114	PROBLEM 4384 4390	masses
T115	TEST 4392 4401	Back exam
T116	PROBLEM 4429 4439	tenderness
T117	PROBLEM 4441 4455	palpable spasm
T118	PROBLEM 4459 4463	pain
T119	PROBLEM 4525 4539	focal findings
T120	PROBLEM 4543 4560	movement disorder
T121	PROBLEM 4589 4605	joint tenderness
T122	PROBLEM 4607 4616	deformity
T123	PROBLEM 4620 4628	swelling
T124	TEST 4644 4661	peripheral pulses
T125	PROBLEM 4673 4684	pedal edema
T126	PROBLEM 4689 4697	clubbing
T127	PROBLEM 4701 4709	cyanosis
T128	PROBLEM 4751 4757	rashes
T129	PROBLEM 4762 4785	suspicious skin lesions
T130	TEST 4921 4924	MRI
T131	TREATMENT 5001 5014	the procedure
T132	TREATMENT 5103 5128	The patient's left breast
T133	TREATMENT 5171 5187	Local anesthesia
T134	TREATMENT 5206 5218	1% lidocaine
T135	TREATMENT 5231 5243	1% lidocaine
T136	TREATMENT 5249 5279	diluted epinephrine Gadolinium
T137	TREATMENT 5304 5313	Gadavist)
T138	PROBLEM 5353 5363	difficulty
T139	TEST 5450 5462	MRI guidance
T140	TREATMENT 5467 5483	grid compression
T141	TREATMENT 5485 5529	a 9 gauge vacuum assisted core biopsy device
T142	TEST 5549 5563	tissue samples
T143	TREATMENT 5565 5582	A titanium marker
T144	TEST 5600 5610	the biopsy
T145	TREATMENT 5634 5643	procedure
T146	PROBLEM 5657 5680	immediate Complications
T147	TEST 5682 5691	Pathology
T148	PROBLEM 5699 5732	proliferative fibrocystic changes
T149	PROBLEM 5741 5747	atypia
T150	TEST 5765 5768	MRI
T151	TEST 5776 5787	core biopsy
T152	PROBLEM 5791 5845	a 4 mm focus of 
 contrastenhancement in the posterior
T153	TEST 5886 5895	Pathology
T154	PROBLEM 5903 5922	fibrocystic changes
T155	TEST 5947 5967	the imaging findings
T156	TEST 5996 6006	breast MRI
T157	TEST 6026 6065	the usual imaging surveillance protocol
T158	TEST 6111 6133	Left Breast Ultrasound
T159	TEST 6169 6190	A targeted ultrasound
T160	TEST 6313 6320	the MRI
T161	TEST 6410 6417	the MRI
T162	PROBLEM 6429 6489	a 4 mm focus of enhancement in the left lower central breast
T163	TEST 6512 6515	MRI
T164	TEST 6516 6529	guided biopsy
T165	PROBLEM 6546 6590	enhancement in the left lower central breast
T166	TEST 6626 6642	this examination
T167	TEST 6774 6790	BI-RADS Category
T168	TEST 6818 6821	MRI
T169	PROBLEM 6887 6922	heterogeneous fibroglandular tissue
T170	PROBLEM 6933 6963	minimal background enhancement
T171	PROBLEM 7011 7049	abnormal areas of contrast enhancement
T172	PROBLEM 7065 7105	Postoperative changes in the left breast
T173	PROBLEM 7111 7138	a seroma in the left breast
T174	PROBLEM 7216 7226	The seroma
T175	PROBLEM 7318 7328	the seroma
T176	PROBLEM 7412 7422	the seroma
T177	TEST 7452 7471	AP, transverse, CC)
T178	PROBLEM 7482 7504	peripheral enhancement
T179	PROBLEM 7517 7527	the seroma
T180	PROBLEM 7538 7570	irregular peripheral enhancement
T181	TEST 7650 7674	postcontrast axial image
T182	TEST 7689 7703	sagittal image
T183	PROBLEM 7773 7783	the seroma
T184	TEST 7785 7809	postcontrast axial image
T185	TEST 7817 7825	sagittal
T186	PROBLEM 7831 7865	The nodular peripheral enhancement
T187	PROBLEM 7919 7949	nodular peripheral enhancement
T188	TEST 8044 8058	sagittal image
T189	PROBLEM 8104 8119	type I kinetics
T190	PROBLEM 8142 8213	the peripheral enhancement of the seroma and the left pectoralis muscle
T191	PROBLEM 8215 8277	4 x 2 x 4 mm focus of enhancement in the posterior left breast
T192	TEST 8287 8311	postcontrast axial image
T193	TEST 8319 8333	sagittal image
T194	TEST 8339 8364	Kinetics curve assessment
T195	PROBLEM 8378 8396	type I enhancement
T196	PROBLEM 8406 8429	diffuse skin thickening
T197	PROBLEM 8449 8470	postoperative changes
T198	PROBLEM 8480 8519	Postoperative seroma in the left axilla
T199	TREATMENT 8525 8562	recent sentinel lymph node dissection
T200	TEST 8602 8621	AP, transverse, CC)
T201	PROBLEM 8655 8666	this seroma
T202	PROBLEM 8691 8741	thin peripheral enhancement surrounding the seroma
T203	PROBLEM 8759 8780	postoperative changes
T204	PROBLEM 8794 8838	axillary or internal mammary lymphadenopathy
T205	TREATMENT 8899 8931	annual mammogramthe right breast
T206	PROBLEM 8978 8988	malignancy
T207	PROBLEM 8990 9022	Irregular peripheral enhancement
T208	PROBLEM 9176 9192	residual disease
T209	PROBLEM 9226 9252	postoperative inflammation
T210	TREATMENT 9259 9276	recent lumpectomy
T211	TEST 9288 9309	surgical consultation
T212	PROBLEM 9311 9355	4 mm focus of enhancement in the left breast
T213	PROBLEM 9367 9384	mildly suspicious
T214	TEST 9401 9420	targeted ultrasound
T215	TEST 9470 9487	MRI guided biopsy
T216	TEST 9504 9525	Sentinel node imaging
T217	PROBLEM 9557 9582	Expected intense activity
T218	PROBLEM 9635 9677	3 foci of tracer uptake in the left axilla
T219	PROBLEM 9698 9718	sentinel lymph nodes
T220	TEST 9734 9762	Left Breast US Guided Biopsy
T221	TEST 9764 9801	Left Post-Biopsy Mammogram  Pathology
T222	PROBLEM 9811 9840	Infiltrating Ductal Carcinoma
T223	TEST 9896 9918	the imaging impression
T224	TREATMENT 9930 9947	surgical excision
T225	TREATMENT 9988 9998	management
T226	TEST 10142 10180	Bilateral Digital Diagnostic Mammogram
T227	PROBLEM 10183 10186	CAD
T228	TEST 10188 10210	Left Breast Ultrasound
T229	TEST 10221 10249	BILATERAL MAMMOGRAM FINDINGS
T230	PROBLEM 10267 10288	heterogeneously dense
T231	PROBLEM 10308 10320	small masses
T232	PROBLEM 10331 10348	an irregular mass
T233	TEST 10451 10474	the tomosynthesis views
T234	TEST 10516 10540	LEFT ULTRASOUND FINDINGS
T235	TEST 10542 10563	A targeted ultrasound
T236	TEST 10651 10661	Ultrasound
T237	PROBLEM 10679 10691	a solid mass
T238	PROBLEM 10863 10892	Solid mass in the left breast
T239	PROBLEM 10917 10927	malignancy
T240	TEST 10930 10959	Ultrasound-guided core biopsy
T241	TEST 11077 11087	ultrasound
T242	TEST 11117 11123	biopsy
T243	PROBLEM 11134 11144	adenopathy
T244	TEST 11146 11167	US guided core biopsy
T245	PROBLEM 11262 11275	Breast cancer
T246	PROBLEM 11329 11347	a T2N1 grade 2 IDC
T247	TEST 11364 11368	Ki67
T248	TEST 11379 11394	her core biopsy
T249	TEST 11397 11401	HER2
T250	TEST 11418 11437	the surgical sample
T251	PROBLEM 11452 11470	gene amplification
T252	TEST 11500 11513	the pathology
T253	TREATMENT 11530 11537	therapy
T254	PROBLEM 11588 11598	the cancer
T255	TEST 11618 11637	her genetic testing
T256	PROBLEM 11656 11674	distant recurrence
T257	TEST 11739 11761	expanded panel testing
T258	TEST 11765 11777	BRCA testing
T259	TEST 11805 11818	her pathology
T260	PROBLEM 11849 11892	small area of positivity at the deep margin
T261	TEST 11896 11919	the re-resection sample
T262	PROBLEM 11932 11961	additional multifocal disease
T263	PROBLEM 11979 11989	the fascia
T264	TREATMENT 12030 12047	radiation therapy
T265	PROBLEM 12072 12082	her cancer
T266	TREATMENT 12102 12123	adjuvant chemotherapy
T267	TEST 12149 12162	her pathology
T268	TREATMENT 12188 12216	any additional node sampling
T269	TREATMENT 12259 12268	radiation
T270	TREATMENT 12277 12292	further surgery
T271	TREATMENT 12331 12340	radiation
T272	TREATMENT 12394 12415	further node sampling
T273	TREATMENT 12442 12454	chemotherapy
T276	PROBLEM 12560 12593	hormone receptor positive disease
T277	TREATMENT 12599 12617	these two regimens
T278	TREATMENT 12642 12644	TC
T279	TREATMENT 12683 12696	scalp cooling
T280	TEST 12798 12818	these recent studies
T281	TREATMENT 12836 12849	scalp cooling
T282	PROBLEM 12866 12875	hair loss
T283	TREATMENT 12907 12936	our scalp cooling coordinator
T284	TREATMENT 13035 13041	a port
T285	TREATMENT 13072 13101	chemotherapy in her right arm
T286	TREATMENT 13158 13176	the port placement
T287	PROBLEM 13228 13259	her cosmesis in the left breast
T288	TREATMENT 13375 13384	radiation
T289	TREATMENT 13405 13423	additional surgery
T290	TREATMENT 13487 13500	ONPRO support
T291	TREATMENT 13515 13536	chemotherapy teaching
T292	TREATMENT 13538 13552	port placement
T293	TEST 13569 13575	PET/CT
T294	TEST 13577 13590	Baseline echo
T295	TREATMENT 13614 13616	AC
T296	TREATMENT 13858 13875	Treatment options
T297	Age 29 31	58
T298	ClinicalCondition 118 131	breast cancer
A1	ContinuityVal T298 new
A2	ExperiencerVal T298 patient
T299	ClinicalCondition 226 239	Breast cancer
A3	ContinuityVal T299 new
T300	Site 246 252	breast
T301	Laterality 241 245	left
R1	LateralityOfSite Arg1:T301 Arg2:T300	
R2	SiteOf Arg1:T300 Arg2:T299	
T302	Datetime 253 263	06/24/2017
R3	HappensAtOnDuring Arg1:T299 Arg2:T302	
T303	Stage 274 277	IIb
T304	TNM 279 285	T2N1M0
T305	Histology 292 295	IDC
A4	HistoryVal T305 new
A5	EpisodeDescription T305 FirstOccurrence
T306	Grade 290 291	2
A6	HistoryVal T306 new
A7	EpisodeDescription T306 FirstOccurrence
T307	BiomarkerName 297 299	ER
A8	HistoryVal T307 new
A9	EpisodeDescription T307 FirstOccurrence
T308	BiomarkerName 304 306	PR
A10	HistoryVal T308 new
A11	EpisodeDescription T308 FirstOccurrence
T309	BiomarkerName 311 320	Her-2-neu
A12	HistoryVal T309 new
A13	EpisodeDescription T309 FirstOccurrence
T310	BiomarkerResult 300 303	pos
A14	HistoryVal T310 new
A15	EpisodeDescription T310 FirstOccurrence
T311	BiomarkerResult 307 310	pos
A16	HistoryVal T311 new
A17	EpisodeDescription T311 FirstOccurrence
T312	BiomarkerResult 321 324	neg
A18	HistoryVal T312 new
A19	EpisodeDescription T312 FirstOccurrence
A20	BiomarkerResultVal T312 Negative
R4	BiomarkerRel Arg1:T312 Arg2:T309	
R5	BiomarkerRel Arg1:T311 Arg2:T308	
R6	BiomarkerRel Arg1:T310 Arg2:T307	
R7	TumorDesc TumorDetails:T299 Desc:T303	
R8	TumorDesc TumorDetails:T299 Desc:T304	
R9	TumorDesc TumorDetails:T299 Desc:T306	
R10	TumorDesc TumorDetails:T299 Desc:T305	
R11	TumorDesc TumorDetails:T299 Desc:T307	
R12	TumorDesc TumorDetails:T299 Desc:T308	
R13	TumorDesc TumorDetails:T299 Desc:T309	
T313	Datetime 327 337	March 2017
T314	Symptom 366 370	mass
A21	IsPresentOnFirstCancerDiagnosis T314 yes
A22	IsCausedByDiagnosedCancer T314 yes
T315	Site 359 365	breast
T316	Laterality 354 358	left
R14	LateralityOfSite Arg1:T316 Arg2:T315	
R15	SiteOf Arg1:T315 Arg2:T314	
R16	HappensAtOnDuring Arg1:T314 Arg2:T313	
T317	Size 381 384	2cm
A23	HistoryVal T317 new
A24	EpisodeDescription T317 FirstOccurrence
T318	Symptom 402 407	pinch
A25	IsPresentOnFirstCancerDiagnosis T318 yes
A26	IsCausedByDiagnosedCancer T318 yes
T319	Site 420 426	breast
T320	Laterality 415 419	left
R17	LateralityOfSite Arg1:T320 Arg2:T319	
R18	SiteOf Arg1:T319 Arg2:T318	
T321	Datetime 453 461	04/10/17
T322	Radiology 468 477	mammogram
A27	IntentVal T322 diagnosis
T323	Site 462 464	BL
R19	SiteOf Arg1:T323 Arg2:T322	
R20	HappensAtOnDuring Arg1:T322 Arg2:T321	
T324	RadPathResult 481 525	irregular mass 20 mm with spiculated margins
A28	RadPathResultVal T324 InitialCancerDiagnosis
T325	Site 529 539	12 o'clock
T326	Laterality 479 480	L
R21	LateralityOfSite Arg1:T326 Arg2:T325	
R22	SiteOf Arg1:T325 Arg2:T324	
R23	ResultOfTest Desc:T324 Test:T322	
T327	Datetime 541 549	04/10/17
T328	Radiology 550 552	US
A29	IntentVal T328 diagnosis
T329	RadPathResult 592 608	solid mass 17 mm
A30	RadPathResultVal T329 InitialCancerDiagnosis
T330	Site 555 586	12 o'clock 2 cm from the nipple
T331	Laterality 553 554	L
R24	LateralityOfSite Arg1:T331 Arg2:T330	
R25	SiteOf Arg1:T330 Arg2:T329	
R26	ResultOfTest Desc:T329 Test:T328	
R27	HappensAtOnDuring Arg1:T328 Arg2:T327	
T332	Datetime 611 619	04/21/17
T333	Pathology 621 649	US Guided Needle Core biopsy
A31	IntentVal T333 diagnosis
T334	Grade 653 654	2
A32	HistoryVal T334 new
A33	EpisodeDescription T334 FirstOccurrence
T335	Histology 655 658	IDC
A34	HistoryVal T335 new
A35	EpisodeDescription T335 FirstOccurrence
T336	BiomarkerName 659 661	ER
A36	HistoryVal T336 new
A37	EpisodeDescription T336 FirstOccurrence
T337	BiomarkerName 668 670	PR
A38	HistoryVal T337 new
A39	EpisodeDescription T337 FirstOccurrence
T338	BiomarkerName 676 681	HER-2
A40	HistoryVal T338 new
A41	EpisodeDescription T338 FirstOccurrence
T339	Pathology 697 702	Ki-67
A42	IntentVal T339 diagnosis
T340	Pathology 709 713	FISH
A43	IntentVal T340 diagnosis
T341	RadPathResult 714 727	not amplified
R28	ResultOfTest Desc:T341 Test:T340	
T342	RadPathResult 703 707	>30%
R29	ResultOfTest Desc:T342 Test:T339	
T343	BiomarkerResult 682 685	neg
A44	HistoryVal T343 new
A45	EpisodeDescription T343 FirstOccurrence
A46	BiomarkerResultVal T343 Negative
T344	BiomarkerResult 670 675	+ 25%
A47	HistoryVal T344 new
A48	EpisodeDescription T344 FirstOccurrence
A49	BiomarkerResultVal T344 Positive
T345	BiomarkerResult 661 667	+ >95%
A50	HistoryVal T345 new
A51	EpisodeDescription T345 FirstOccurrence
A52	BiomarkerResultVal T345 Positive
R30	BiomarkerRel Arg1:T336 Arg2:T345	
R31	BiomarkerRel Arg1:T337 Arg2:T344	
R32	BiomarkerRel Arg1:T338 Arg2:T343	
R33	TestOrProcedureReveals Test:T333 Desc:T334	
R34	TestOrProcedureReveals Test:T333 Desc:T335	
R35	TestOrProcedureReveals Test:T333 Desc:T336	
R36	TestOrProcedureReveals Test:T333 Desc:T337	
R37	TestOrProcedureReveals Test:T333 Desc:T338	
T346	Datetime 729 737	04/30/17
T347	ProcedureName 743 753	lumpectomy
A53	IntentVal T347 treatment-curative
A54	TreatmentTypeVal T347 local
A55	TreatmentCategory T347 Others
T348	ProcedureName 758 763	SLNBx
A56	IntentVal T348 staging
T349	Site 738 742	Left
R38	SiteOf Arg1:T349 Arg2:T347	
R39	HappensAtOnDuring Arg1:T347 Arg2:T346	
R40	HappensAtOnDuring Arg1:T348 Arg2:T346	
T350	Grade 793 794	2
A57	HistoryVal T350 new
A58	EpisodeDescription T350 FirstOccurrence
T351	Histology 795 798	IDC
A59	HistoryVal T351 new
A60	EpisodeDescription T351 FirstOccurrence
T352	Size 800 805	3.6cm
A61	HistoryVal T352 new
A62	EpisodeDescription T352 FirstOccurrence
T353	LocalInvasion 807 808	+
A63	HistoryVal T353 new
A64	EpisodeDescription T353 FirstOccurrence
T354	MarginStatus 822 830	positive
A65	MarginVal T354 positive
T355	LymphNodeInvolvement 832 847	2/2 lymph nodes
A66	HistoryVal T355 new
A67	EpisodeDescription T355 FirstOccurrence
R41	TestOrProcedureReveals Test:T347 Desc:T350	
A68	IsTumorRemaining T347 yes
R42	TestOrProcedureReveals Test:T347 Desc:T351	
R43	TestOrProcedureReveals Test:T347 Desc:T352	
R44	TestOrProcedureReveals Test:T347 Desc:T353	
R45	ProcedureDesc Procedure:T347 Desc:T354	
R46	TestOrProcedureReveals Test:T348 Desc:T355	
T356	Radiology 919 922	MRI
A69	IntentVal T356 TreatmentAssessment
T357	Datetime 923 931	05/06/17
R47	HappensAtOnDuring Arg1:T356 Arg2:T357	
T358	Site 1046 1052;1056 1065	breast 6 o'clock
T359	Laterality 1044 1045	L
R48	LateralityOfSite Arg1:T359 Arg2:T358	
T360	RadPathResult 1012 1036	4mm focus of enhancement
A70	RadPathResultVal T360 TreatmentResponse
R49	SiteOf Arg1:T358 Arg2:T360	
T361	RadPathResult 932 973	enhancement surrounding the surgical site
A71	RadPathResultVal T361 TreatmentResponse
R50	ResultOfTest Desc:T360 Test:T356	
R51	ResultOfTest Desc:T361 Test:T356	
T362	Pathology 1069 1086	MRI guided biopsy
A72	IntentVal T362 diagnosis
T363	Datetime 1087 1095	05/20/17
R52	HappensAtOnDuring Arg1:T362 Arg2:T363	
T364	RadPathResult 1129 1176	proliferative fibrocystic change without atypia
A73	RadPathResultVal T364 NoDisease
R53	ResultOfTest Desc:T364 Test:T362	
T365	Datetime 1180 1188	05/19/17
T366	GenomicTest 1189 1193	BRCA
A74	GenomicTestType T366 Germline
T367	GenomicTestResult 1199 1207	negative
A75	GenomicTestType T367 Germline
R54	HappensAtOnDuring Arg1:T366 Arg2:T365	
R55	ResultOfTest Desc:T367 Test:T366	
T368	Datetime 1265 1273	06/04/17
T369	ProcedureName 1274 1294	Surgical re-excision
A76	IntentVal T369 treatment-curative
A77	TreatmentTypeVal T369 local
A78	TreatmentCategory T369 Others
T370	Site 1300 1306	breast
T371	Laterality 1295 1299	left
R56	LateralityOfSite Arg1:T371 Arg2:T370	
T372	ProcedureName 1308 1330	lumpectomy re-excision
A79	IntentVal T372 treatment-curative
A80	TreatmentTypeVal T372 local
A81	TreatmentCategory T372 Others
R57	SiteOf Arg1:T370 Arg2:T369	
R58	SiteOf Arg1:T370 Arg2:T372	
T373	Histology 1343 1346	IDC
A82	HistoryVal T373 new
A83	EpisodeDescription T373 FirstOccurrence
T374	Size 1353 1356	2cm
A84	HistoryVal T374 new
A85	EpisodeDescription T374 FirstOccurrence
R59	TestOrProcedureReveals Test:T372 Desc:T373	
R60	TestOrProcedureReveals Test:T372 Desc:T374	
T375	Histology 1361 1379	Invasive carcinoma
A86	HistoryVal T375 new
A87	EpisodeDescription T375 FirstOccurrence
R61	TestOrProcedureReveals Test:T372 Desc:T375	
T376	Size 1667 1676	6mm x 4mm
A88	HistoryVal T376 new
A89	EpisodeDescription T376 FirstOccurrence
R62	TestOrProcedureReveals Test:T372 Desc:T376	
T377	ProcedureName 1841 1863	lumpectomy re-excision
A90	IntentVal T377 treatment-curative
A91	TreatmentTypeVal T377 local
A92	TreatmentCategory T377 Others
T378	Datetime 1867 1877	06/04/2107
R63	HappensAtOnDuring Arg1:T377 Arg2:T378	
T379	Symptom 1824 1828	pain
T380	Site 1817 1823	breast
T381	Laterality 1812 1816	left
R64	LateralityOfSite Arg1:T381 Arg2:T380	
R65	SiteOf Arg1:T380 Arg2:T379	
T382	SDoH 1988 2030	supportive family/friends that live nearby
T383	ClinicalCondition 2210 2223	Breast cancer
T384	Datetime 2237 2247	March 2017
T385	Site 2230 2236	breast
T386	Laterality 2225 2229	left
R66	LateralityOfSite Arg1:T386 Arg2:T385	
R67	SiteOf Arg1:T385 Arg2:T383	
R68	HappensAtOnDuring Arg1:T383 Arg2:T384	
T387	ProcedureName 2313 2357	BIOPSY / EXCISION / DISSECTION AXILLARY NODE
A93	IntentVal T387 staging
T388	Site 2358 2362	Left
R69	SiteOf Arg1:T388 Arg2:T387	
T389	ProcedureName 2368 2427	MASTECTOMY PARTIAL / LUMPECTOMY W/ AXILLARY LYMPHADENECTOMY
A94	IntentVal T389 DiagnosisAndTreatment
A95	TreatmentTypeVal T389 local
A96	TreatmentCategory T389 Others
T390	Site 2428 2432	Left
R70	SiteOf Arg1:T390 Arg2:T389	
T391	Datetime 2433 2443	04/30/2017
R71	HappensAtOnDuring Arg1:T387 Arg2:T391	
R72	HappensAtOnDuring Arg1:T389 Arg2:T391	
T392	ClinicalCondition 2499 2512	Breast cancer
A97	ExperiencerVal T392 family
T393	ClinicalCondition 2541 2554	Breast cancer
A98	ExperiencerVal T393 family
T394	ClinicalCondition 2576 2589	Breast cancer
A99	ExperiencerVal T394 family
T395	ClinicalCondition 2604 2617	Breast cancer
A100	ExperiencerVal T395 family
T396	Age 2534 2536	35
T397	Age 2569 2571	70
T398	Age 2597 2599	37
T399	Age 2625 2627	42
R73	HappensAtOnDuring Arg1:T396 Arg2:T392	
R74	HappensAtOnDuring Arg1:T393 Arg2:T397	
R75	HappensAtOnDuring Arg1:T394 Arg2:T398	
R76	HappensAtOnDuring Arg1:T395 Arg2:T399	
T400	SectionSkip 2679 2897	Breast cancer Paternal Grandmother 35    Breast cancer Paternal Aunt   diagnosed in her late 70s, mother of the 2 sisters below    Breast cancer Other   Paternal Cousin x 2, they are sisters, diagnosed at 37 and 42yo
A101	SectionSkipType T400 copy_forward
T401	PatientCharacteristics 2902 2907	G2 P2
T402	PatientCharacteristics 2916 2932	first pregnancy:
T403	Age 2933 2935	22
T404	PatientCharacteristics 2944 2952	menarche
T405	Age 2954 2956	14
T406	ClinicalCondition 2965 2974	menopause
T407	Age 2976 2978	42
R77	HappensAtOnDuring Arg1:T402 Arg2:T403	
R78	BeginsOnOrAt Arg1:T404 Arg2:T405	
R79	BeginsOnOrAt Arg1:T406 Arg2:T407	
T408	TreatmentType 2989 3016	hormone replacement therapy
A102	NegationModalityVal T408 negated
T409	Allergy 3064 3075	Penicillins
T410	MaritalStatus 3134 3142	Divorced
T411	LivingCondition 3144 3155	lives alone
T412	PatientCharacteristics 3159 3163	G2P2
T413	SDoH 3165 3188	36 and 25 year old sons
T414	Employment 3192 3233	Works as a ***** ***** in the ***** *****
T415	PatientCharacteristics 3237 3240	LMP
T416	Age 3245 3247	42
R80	HappensAtOnDuring Arg1:T415 Arg2:T416	
T417	TreatmentType 3281 3284	HRT
A103	NegationModalityVal T417 negated
A104	SectionSkipType T7 medications
T418	SectionSkip 3531 3877;3880 4791	BP 132/85 | Pulse 69 | Temp 36.5 C (97.7 F) (Oral)  | Resp 16 | Ht 160 cm (5' 3") Comment: June 2017 @ ***** | Wt 57.9 kg (127 lb 9.6 oz) | SpO2 98% | BMI 22.6 kg/m2  Physical Examination: General appearance - alert, well appearing, and in no distress  Mental status - alert, oriented to person, place, and time  Eyes - pupils equal and reactive, extraocular eye movements intact  Mouth - mucous membranes moist, pharynx normal without lesions  Neck - supple, no significant adenopathy  Lymphatics - no palpable lymphadenopathy   Chest - clear to auscultation, no wheezes, rales or rhonchi, symmetric air entry,  Heart - normal rate, regular rhythm, normal S1, S2, no murmurs, rubs, clicks or gallops  Abdomen - soft, nontender, nondistended, no masses or organomegaly  Breasts - Left breast with periareolar scar and distortion  Right breast with no masses  Back exam - full range of motion, no tenderness, palpable spasm or pain on motion  Neurological - alert, oriented, normal speech, no focal findings or movement disorder noted  Musculoskeletal - no joint tenderness, deformity or swelling  Extremities - peripheral pulses normal, no pedal edema, no clubbing or cyanosis  Skin - normal coloration and turgor, no rashes, no suspicious skin lesions noted
A105	SectionSkipType T418 physical_exam
T419	Datetime 4910 4920	05/20/2017
T420	Pathology 4921 4924;4932 4934	MRI BX
A106	IntentVal T420 diagnosis
T421	Site 4925 4931	BREAST
R81	SiteOf Arg1:T421 Arg2:T420	
R82	HappensAtOnDuring Arg1:T420 Arg2:T419	
A107	SectionSkipType T10 radiology_report
T422	RadPathResult 5699 5747	proliferative fibrocystic changes without atypia
A108	RadPathResultVal T422 NoDisease
R83	ResultOfTest Desc:T422 Test:T420	
T423	Datetime 6100 6110	05/09/2017
T424	Radiology 6123 6133	Ultrasound
A110	IntentVal T424 diagnosis
T425	Site 6116 6122	Breast
T426	Laterality 6111 6115	Left
R84	LateralityOfSite Arg1:T426 Arg2:T425	
R85	SiteOf Arg1:T425 Arg2:T424	
R86	HappensAtOnDuring Arg1:T424 Arg2:T423	
T13	SectionSkip 6143 6803	LEFT ULTRASOUND FINDINGS: A targeted ultrasound was performed of the left breast at 6 o'clock located 3 centimeters from the nipple. There is no sonographic correlate to the MRI finding in the left lower central breast  IMPRESSION  There is no sonographic finding to the MRI finding of a 4 mm focus of enhancement in the left lower central breast. Therefore, recommend MRI-guided biopsy of the focus of enhancement in the left lower central breast, as per MRI report. The results of this examination were reviewed directly with the patient by a member of the Breast Health Center, and a written summary report was provided to her. BI-RADS Category 1 : Negative
A111	SectionSkipType T13 radiology_report
T427	Datetime 6807 6817	05/06/2017
T428	Radiology 6818 6821;6839 6851	MRI WWO CONTRAST
A112	IntentVal T428 diagnosis
T429	Site 6822 6828	BREAST
T430	Laterality 6829 6838	BILATERAL
R87	LateralityOfSite Arg1:T430 Arg2:T429	
R88	SiteOf Arg1:T429 Arg2:T428	
R89	HappensAtOnDuring Arg1:T428 Arg2:T427	
T431	SectionSkip 6853 7750;7753 8838	FINDINGS: The breasts demonstrate heterogeneous fibroglandular tissue. There is minimal background enhancement that is symmetric.  Right breast: There are no abnormal areas of contrast enhancement.  Left breast: Postoperative changes in the left breast with a seroma in the left breast at 12:00 extending from the nipple areolar complex to the pectoralis muscle. The seroma measures 8.6 x 4.6 cm (AP, transverse). The craniocaudal extent of the anterior portion of the seroma measures 5.1 cm in the posterior portion measures 2.9 cm. The posterior portion of the seroma measures 3.4 x 1.1 x 2.9 cm (AP, transverse, CC). There is peripheral enhancement surrounding the seroma. There is irregular peripheral enhancement along the anterolateral superior margin of the anterior portion of the seroma (postcontrast axial image 54 and 49 and sagittal image 32) and along the posterolateral aspect of the anterior portion of the seroma (postcontrast axial image 42 and sagittal 39). The nodular peripheral enhancement extends to the nipple areolar complex. There is also nodular peripheral enhancement along the medial margin of the anterior portion of the seroma(postcontrast axial image 45 and sagittal image 53). The peripheral enhancement demonstrates type I kinetics. No fat plane between the peripheral enhancement of the seroma and the left pectoralis muscle. 4 x 2 x 4 mm focus of enhancement in the posterior left breast at 6:00 (postcontrast axial image 72 and sagittal image 44). Kinetics curve assessment demonstrates type I enhancement There is diffuse skin thickening, likely related to postoperative changes.  Other: Postoperative seroma in the left axilla from recent sentinel lymph node dissection measuring 6.6 x 4.0 x at least 5.5 cm (AP, transverse, CC). The full craniocaudad extent of this seroma is not imaged. There is thin peripheral enhancement surrounding the seroma, which is due to postoperative changes. There is no axillary or internal mammary lymphadenopathy
A113	SectionSkipType T431 radiology_report
T432	ClinicalCondition 11262 11275	Breast cancer
A114	ContinuityVal T432 new
T433	Site 11282 11288	breast
T434	Laterality 11277 11281	left
R90	LateralityOfSite Arg1:T434 Arg2:T433	
R91	SiteOf Arg1:T433 Arg2:T432	
T435	Age 11291 11293	58
R92	HappensAtOnDuring Arg1:T432 Arg2:T435	
T436	PatientCharacteristics 11303 11317	postmenopausal
T437	TNM 11331 11335	T2N1
A115	HistoryVal T437 new
A116	EpisodeDescription T437 FirstOccurrence
T438	Grade 11342 11343	2
A117	HistoryVal T438 new
A118	EpisodeDescription T438 FirstOccurrence
T439	Histology 11344 11347	IDC
A119	HistoryVal T439 new
A120	EpisodeDescription T439 FirstOccurrence
T440	Pathology 11364 11368	Ki67
T441	RadPathResult 11372 11375	30%
T442	Pathology 11383 11394	core biopsy
A121	IntentVal T442 diagnosis
R93	ResultOfTest Desc:T441 Test:T440	
R94	TumorDesc TumorDetails:T432 Desc:T437	
R95	TumorDesc TumorDetails:T432 Desc:T439	
R96	TumorDesc TumorDetails:T432 Desc:T438	
T443	Pathology 11474 11478	FISH
A122	IntentVal T443 diagnosis
T444	RadPathResult 11449 11470	no gene amplification
R97	ResultOfTest Desc:T444 Test:T443	
T12	Pathology 5765 5787	MRI-guided core biopsy
T445	Site 5847 5866;5879 5885	lower (6:00) region breast
T446	Laterality 5874 5878	left
R98	LateralityOfSite Arg1:T446 Arg2:T445	
R99	SiteOf Arg1:T445 Arg2:T12	
T447	RadPathResult 5903 5922	fibrocystic changes
A109	RadPathResultVal T447 NoDisease
R100	ResultOfTest Desc:T447 Test:T12	
T448	Radiology 5996 6006	breast MRI
A123	NegationModalityVal T448 hypothetical_in_future
A124	IntentVal T448 screening
T449	Duration 6010 6018	6 months
R101	HappensAfter Arg1:T448 Arg2:T449	
T450	RadPathResult 8879 8887	Negative
A125	RadPathResultVal T450 NoDisease
T451	Site 8860 8866	breast
T452	Laterality 8854 8859	Right
R102	LateralityOfSite Arg1:T452 Arg2:T451	
R103	SiteOf Arg1:T451 Arg2:T450	
R104	ResultOfTest Desc:T450 Test:T428	
T453	Site 8939 8945	breast
T454	Laterality 8934 8938	Left
R105	LateralityOfSite Arg1:T454 Arg2:T453	
T455	RadPathResult 8947 8957	BI-RADS 4C
A126	RadPathResultVal T455 Unclear
R106	SiteOf Arg1:T453 Arg2:T455	
R107	ResultOfTest Desc:T455 Test:T428	
T456	Datetime 9490 9500	04/30/2017
T457	Radiology 9504 9525	Sentinel node imaging
A127	IntentVal T457 staging
T458	Site 9538 9544	breast
T459	Laterality 9533 9537	left
R108	LateralityOfSite Arg1:T459 Arg2:T458	
R109	SiteOf Arg1:T458 Arg2:T457	
R110	HappensAtOnDuring Arg1:T457 Arg2:T456	
T460	RadPathResult 9635 9695;9698 9718	3 foci of tracer uptake in the left axilla,  compatible with sentinel lymph nodes
A128	RadPathResultVal T460 Others
R111	ResultOfTest Desc:T460 Test:T457	
T461	Datetime 9723 9733	04/21/2017
T462	Pathology 9746 9763	US Guided Biopsy,
A129	IntentVal T462 diagnosis
T463	Site 9739 9745	Breast
T464	Laterality 9734 9738	Left
R112	LateralityOfSite Arg1:T464 Arg2:T463	
R113	SiteOf Arg1:T463 Arg2:T462	
R114	HappensAtOnDuring Arg1:T462 Arg2:T461	
T17	Histology 9811 9840	Infiltrating Ductal Carcinoma
R115	TestOrProcedureReveals Test:T462 Desc:T17	
T465	Datetime 10131 10141	04/10/2017
T466	Radiology 10152 10159;10171 10180	Digital Mammogram
A130	IntentVal T466 diagnosis
T467	Site 10142 10151	Bilateral
R116	SiteOf Arg1:T467 Arg2:T466	
T468	Radiology 10200 10210	Ultrasound
T469	Site 10193 10199	Breast
T470	Laterality 10188 10192	Left
R117	LateralityOfSite Arg1:T470 Arg2:T469	
R118	SiteOf Arg1:T469 Arg2:T468	
A131	IntentVal T468 diagnosis
R119	HappensAtOnDuring Arg1:T466 Arg2:T465	
R120	HappensAtOnDuring Arg1:T468 Arg2:T465	
A132	SectionSkipType T18 radiology_report
T471	ClinicalCondition 11592 11598	cancer
T472	GenomicTest 11622 11637	genetic testing
A133	GenomicTestType T472 Unclear
T473	TreatmentType 12030 12039	radiation
T474	TreatmentType 12111 12123	chemotherapy
A134	NegationModalityVal T474 hypothetical_in_future
A135	TreatmentTypeVal T474 adjuvant
A136	TreatmentIntentVal T474 curative
T475	ProcedureName 12203 12216	node sampling
A137	IntentVal T475 staging
A138	TreatmentCategory T475 Others
T476	TreatmentType 12259 12268	radiation
A139	TreatmentTypeVal T476 adjuvant
T477	TreatmentType 12285 12292	surgery
A140	TreatmentTypeVal T477 local
T478	TreatmentType 12331 12340	radiation
A141	TreatmentTypeVal T478 adjuvant
T479	TreatmentType 12442 12454	chemotherapy
A142	TreatmentTypeVal T479 adjuvant
T274	MedicationName 12476 12478	AC
A143	NegationModalityVal T274 hypothetical_in_future
A144	TreatmentTypeVal T274 adjuvant
A145	TreatmentIntentVal T274 curative
A146	TreatmentCategory T274 AntiNeoPlastics
T275	MedicationName 12486 12487	T
A147	NegationModalityVal T275 hypothetical_in_future
A148	TreatmentTypeVal T275 adjuvant
A149	TreatmentIntentVal T275 curative
A150	TreatmentCategory T275 AntiNeoPlastics
T480	MedicationName 12491 12493	TC
A151	NegationModalityVal T480 hypothetical_in_future
A152	TreatmentTypeVal T480 adjuvant
A153	TreatmentIntentVal T480 curative
A154	TreatmentCategory T480 AntiNeoPlastics
T481	Frequency 12479 12485	weekly
R121	Temporal Arg1:T481 Arg2:T274	
T482	Cycles 12496 12497	4
R122	TreatmentDesc Therapy:T480 Desc:T482	
R123	TreatmentDesc Therapy:T275 Desc:T482	
T483	MedicationName 12642 12644	TC
A155	NegationModalityVal T483 hypothetical_in_future
A156	TreatmentTypeVal T483 adjuvant
A157	TreatmentIntentVal T483 curative
A158	TreatmentCategory T483 AntiNeoPlastics
T484	TreatmentType 12683 12696	scalp cooling
A159	TreatmentTypeVal T484 others
T485	MedicationName 12782 12784	TC
A160	NegationModalityVal T485 hypothetical_in_future
A161	TreatmentTypeVal T485 adjuvant
A162	TreatmentIntentVal T485 curative
A163	TreatmentCategory T485 AntiNeoPlastics
T486	Cycles 12787 12788	6
R124	TreatmentDesc Therapy:T485 Desc:T486	
T487	TreatmentType 12836 12849	scalp cooling
T488	Symptom 12866 12875	hair loss
A164	NegationModalityVal T488 hypothetical_in_future
R125	TreatmentAdministeredForProblem Treatment:T487 Prob:T488	
T489	TreatmentType 13072 13084	chemotherapy
A165	NegationModalityVal T489 hypothetical_in_future
A166	TreatmentTypeVal T489 adjuvant
A167	TreatmentIntentVal T489 curative
T490	ProcedureName 13162 13176	port placement
A168	NegationModalityVal T490 hypothetical_in_future
A169	TreatmentCategory T490 Others
T491	TreatmentType 13375 13384	radiation
A170	NegationModalityVal T491 hypothetical_in_future
A171	TreatmentTypeVal T491 adjuvant
A172	TreatmentIntentVal T491 curative
T492	MedicationName 13475 13477	TC
A173	NegationModalityVal T492 planned_in_future
A174	TreatmentTypeVal T492 adjuvant
A175	TreatmentIntentVal T492 curative
A176	TreatmentCategory T492 AntiNeoPlastics
T493	Cycles 13480 13481	6
R126	TreatmentDesc Therapy:T492 Desc:T493	
T494	MedicationName 13487 13492	ONPRO
A177	NegationModalityVal T494 planned_in_future
A178	TreatmentTypeVal T494 others
A179	TreatmentCategory T494 Supportive
T495	ProcedureName 13538 13552	port placement
T496	Radiology 13569 13575	PET/CT
A180	NegationModalityVal T496 hypothetical_in_future
A181	IntentVal T496 staging
T497	Radiology 13586 13590	echo
A182	IntentVal T497 others
T498	Datetime 13642 13650	07/09/17
T499	TreatmentType 13656 13664	dignicap
A183	TreatmentTypeVal T499 others
A184	TreatmentIntentVal T499 others
R127	HappensAtOnDuring Arg1:T499 Arg2:T498	
T500	MedicationName 13614 13616	AC
A185	NegationModalityVal T500 negated
A186	TreatmentTypeVal T500 adjuvant
A187	TreatmentIntentVal T500 curative
A188	TreatmentCategory T500 AntiNeoPlastics
R128	SizeOf Arg1:T317 Arg2:T314	
R129	HappensAtOnDuring Arg1:T332 Arg2:T333	
R130	SizeOf Arg1:T352 Arg2:T351	
T501	Size 866 871	1.8cm
R131	SizeOf Arg1:T501 Arg2:T355	
R132	HappensAtOnDuring Arg1:T368 Arg2:T369	
R133	HappensAtOnDuring Arg1:T368 Arg2:T372	
R134	SizeOf Arg1:T374 Arg2:T373	
R135	SiteOf Arg1:T370 Arg2:T375	
R136	SizeOf Arg1:T376 Arg2:T373	
T502	Size 1729 1736	2 x 1mm
T503	Site 1748 1769	deep resection margin
R137	SiteOf Arg1:T503 Arg2:T502	
R138	SizeOf Arg1:T502 Arg2:T373	
R139	LateralityOfSite Arg1:T371 Arg2:T503	
T504	Site 1680 1693	cross section
R140	SiteOf Arg1:T504 Arg2:T376	
R141	LateralityOfSite Arg1:T371 Arg2:T504	
T505	Site 1383 1413	deep margin in one small focus
R142	SiteOf Arg1:T505 Arg2:T375	
R143	LateralityOfSite Arg1:T371 Arg2:T505	
T506	SectionSkip 8990 9488	Irregular peripheral enhancement along the anterior, anterolateral, medial, and posterolateral aspect of the anterior portion of the seroma in the left breast at 12:00 is suspicious for residual disease. Differential diagnosis includes postoperative inflammation given recent lumpectomy. Recommend surgical consultation. 4 mm focus of enhancement in the left breast at 6:00 is mildly suspicious (4A). Recommend targeted ultrasound. If there is no sonographic correlate, recommend MRI guided biopsy.
A189	SectionSkipType T506 radiology_report
T507	Pathology 689 692	IHC
T508	RadPathResult 693 695	1+
R144	ResultOfTest Desc:T508 Test:T507	
R145	TestOrProcedureConductedForProblem Test:T377 Prob:T379	
T509	Pathology 11809 11818	pathology
A190	IntentVal T509 diagnosis
T510	RadPathResult 11840 11961	possible small area of positivity at the deep margin on the re-resection sample, as well as additional multifocal disease
A191	RadPathResultVal T510 Unclear
R146	ResultOfTest Desc:T510 Test:T509	
A192	NegationModalityVal T473 planned_in_future
A193	NegationModalityVal T476 planned_in_future
A194	NegationModalityVal T477 hypothetical_in_future
A195	NegationModalityVal T478 planned_in_future
A196	NegationModalityVal T479 planned_in_future
A197	NegationModalityVal T495 planned_in_future
T511	Radiology 8906 8915	mammogram
A198	NegationModalityVal T511 hypothetical_in_future
A199	IntentVal T511 screening
T512	Frequency 8899 8905	annual
T513	Site 8925 8931	breast
T514	Laterality 8919 8924	right
R147	LateralityOfSite Arg1:T514 Arg2:T513	
R148	SiteOf Arg1:T513 Arg2:T511	
R149	Temporal Arg1:T511 Arg2:T512	
T515	DiseaseState 11664 11674	recurrence
A200	NegationModalityVal T515 hypothetical_in_future
A201	DiseaseStateVal T515 progression-recurrence
A202	NegationModalityVal T475 hypothetical_in_future
T516	ProcedureName 12402 12415	node sampling
A203	NegationModalityVal T516 hypothetical_in_future
A204	IntentVal T516 staging
A205	TreatmentCategory T516 Others
T517	ClinicalCondition 12586 12593	disease
A206	ExperiencerVal T517 others
T518	BiomarkerName 12560 12576	hormone receptor
A207	ExperiencerVal T518 others
T519	BiomarkerResult 12577 12585	positive
A208	ExperiencerVal T519 others
A209	BiomarkerResultVal T519 Positive
R150	BiomarkerRel Arg1:T518 Arg2:T519	
R151	TumorDesc TumorDetails:T518 Desc:T517	
R152	InclusionCriteriaFor Arg1:T518 Arg2:T485	
A210	NegationModalityVal T487 hypothetical_in_future
A211	NegationModalityVal T484 hypothetical_in_future
A212	NegationModalityVal T497 planned_in_future
T520	hpi_start 0 3	HPI
T521	hpi_end 2151 2157	*****.
T522	ap_start 11190 11200	Assessment
T523	ap_end 13850 13856	given.
